Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport in primary myofascial pain syndrome
NCT00149240Phase 2Completed
- Sponsor
- Ipsen
- Start
- Jan 2005
- Primary completion
- Feb 2006
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of abobotulinumtoxinA in Myofascial Pain Syndrome (MPS), sponsored by Ipsen. Started Jan 2005; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
Myofascial Pain Syndrome (MPS)
Beyond the preview
Go deeper on NCT00149240.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00149240.